期刊文献+

铁死亡及其在炎症性肠病中对肠上皮细胞作用机制的研究进展 被引量:1

Research progress of ferroptosis and its mechanism of action on intestinal epithelial cells in inflammatory bowel disease
下载PDF
导出
摘要 炎症性肠病(inflammatory bowel disease,IBD)主要表现为慢性进行性胃肠道炎症,损害胃肠道黏膜。越来越多的研究证明,炎症部位存在失调的细胞死亡,导致肠道机械屏障的破坏和炎症反应的加重。铁死亡是一种新发现的铁依赖的、脂质氧化介导的细胞死亡形式。已有多篇文献报道了IBD患者的肠道出现铁死亡相关因子的异常,鉴于当前IBD具体发病机制尚不明确,且治疗尚存在诸多局限,因此,该文总结了近年来铁死亡机制的研究进展,并重点阐述了铁死亡在IBD发病机制中的潜在作用,为未来IBD发病机制的研究与治疗药物的开发运用提供方向。 Inflammatory bowel disease(IBD)is a chronic progressive inflammation of the gastrointestinal tract that damages the mucous membrane of the gastrointestinal tract.A growing number of studies have demonstrated that dysfunctional cell death occurs at inflammatory sites,leading to the destruction of the intestinal mechanical barrier and aggravation of inflammatory responses.Ferroptosis is a newly discovered form of programmed cell death mediated by iron-dependent lipid oxidation.There have been many articles that reported intestinal abnormal related factors of ferroptosis in patients with IBD.In view of the unclear current IBD specific pathogenesis and the many limitations in treatment,we summarize the research progress of ferroptosis mechanism in recent years,and expound the potential role of ferroptosis in the pathogenesis of IBD,aiming to provide direction for the future study of the pathogenesis of IBD and the development and application of therapeutic drugs.
作者 陈双兰 刘青松 胡双元 张怡 刘蓉 CHEN Shuang-lan;LIU Qing-song;HU Shuang-yuan;ZHANG Yi;LIU Rong(Dept of Gastroenterology,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,School of Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2023年第12期2210-2215,共6页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81973821)。
关键词 铁死亡 炎症性肠病 肠上皮细胞 氧化应激 机制 研究进展 ferroptosis inflammatory bowel disease intestinal epithelial cells oxidative stress mechanism research progress
  • 相关文献

参考文献2

二级参考文献46

  • 1Ziegler EE, Nelson SE, Jeter JM. Iron supplementation of breastfed infants from an early age. Am J Clin Nutr 2009; 89: 525-532.
  • 2Zimmermann MB, Chassard C, Rohner F, N'goran EK, Nindjin C, Dostal A, Utzinger J, Ghattas H, Lacroix C, Hur- tell RF. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d' Ivoire. Am J Clin Nutr 2010; 92:1406-1415.
  • 3Choi YJ, Im E, Chung HK, Pothoulakis C, Rhee SH. TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells. J Biol Chem 2010; 285:37570-37578.
  • 4Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut micro- biota in health and disease. Physiol Rev 2010; 90:859-904.
  • 5Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-1638.
  • 6Rajilic-Stojanovic M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007; 9:2125-2136.
  • 7Cani PD, Delzenne NM, Amar J, Burcelin R. Role of gut mi- croflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) 2008; 56: 305-309.
  • 8Blaut M, Collins MD, Welling GW, Dore J, van Loo J, de Vos W. Molecular biological methods for studying the gut mi- crobiota: the EU human gut flora project. Br J Nutr 2002; 87 Suppl 2:$203-$211.
  • 9Seksik P, Rigottier-Gois L, Gramet G, Sutren M, IJochart P, Marteau P, Jian R, Dore J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the co- lon. Gut 2003; 52:237-242.
  • 10Rehman A, Lepage P, Nolte A, Hellmig S, Schreiber S, Ott SJ. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 2010; 59:1114-1122.

共引文献4

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部